Factors associated with fingolimod rebound: A single center real-life experience

•Rebound occurs in about 10% of MS patients who discontinued fingolimod.•Rebound was more common in younger patients.•Long washout period after discontinuation of fingolimod may increase the likelihood of rebound. Background It is still controversial whether the relapse experienced after discontinua...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis and related disorders 2021-11, Vol.56, p.103278-103278, Article 103278
Hauptverfasser:	Goncuoglu, Cansu, Tuncer, Asli, Bayraktar-Ekincioglu, Aygin, Ayvacioglu Cagan, Cansu, Acar-Ozen, Pinar, Cakan, Melike, Karabulut, Erdem, Karabudak, Rana
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Clinical Neurology Discontinuation Disease modifying therapy Fingolimod Fingolimod Hydrochloride - adverse effects Humans Immunosuppressive Agents - adverse effects Life Sciences & Biomedicine Magnetic Resonance Imaging Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Neurosciences & Neurology Rebound Recurrence Retrospective Studies Science & Technology Washout
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!